Go Pro
NASDAQ:BNBX

Applied Dna Sciences (BNBX) Stock Price, News & Analysis

Applied Dna Sciences logo
$0.15 0.00 (0.00%)
As of 03:53 PM Eastern

About Applied Dna Sciences Stock (NASDAQ:BNBX)

Advanced

Key Stats

Today's Range
$0.14
$0.18
50-Day Range
$0.08
$0.54
52-Week Range
$0.07
$7.15
Volume
125,480 shs
Average Volume
489,772 shs
Market Capitalization
$1.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers. The company supports those markers with laboratory services—using PCR and sequencing techniques—to analyze samples, produce digital chain-of-custody reports and provide verification for customers. Its business model includes product sales, licensing and contract testing or integration work tailored to customer requirements.

Applied DNA’s solutions are used by organizations that need robust provenance and anti-counterfeiting measures, including manufacturers, distributors and entities in regulated industries. The company provides services to customers in the United States and internationally, seeking to address global supply-chain vulnerabilities by combining intellectual property, laboratory capability and field-deployable tagging technologies. Applied DNA Sciences is publicly traded on the NASDAQ.

AI Generated. May Contain Errors.

Applied Dna Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

BNBX MarketRank™: 

Applied Dna Sciences scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Applied Dna Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Applied Dna Sciences has received no research coverage in the past 90 days.

  • Read more about Applied Dna Sciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Applied Dna Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Applied Dna Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Applied Dna Sciences has a P/B Ratio of 0.10. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.57% of the float of Applied Dna Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Applied Dna Sciences has a short interest ratio ("days to cover") of 0.64, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Applied Dna Sciences has recently increased by 213.01%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Applied Dna Sciences does not currently pay a dividend.

  • Dividend Growth

    Applied Dna Sciences does not have a long track record of dividend growth.

    • Insider Buying vs. Insider Selling

      In the past three months, Applied Dna Sciences insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      6.14% of the stock of Applied Dna Sciences is held by insiders.

    • Percentage Held by Institutions

      22.22% of the stock of Applied Dna Sciences is held by institutions.

    • Read more about Applied Dna Sciences' insider trading history.
    Receive BNBX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Applied Dna Sciences and its competitors with MarketBeat's FREE daily newsletter.

    SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    BNBX Stock News Headlines

    See More Headlines

    BNBX Stock Analysis - Frequently Asked Questions

    Applied Dna Sciences' stock was trading at $1.51 on January 27, 2026. Since then, BNBX stock has decreased by 90.1% and is now trading at $0.15.

    Applied Dna Sciences Inc (NASDAQ:BNBX) released its quarterly earnings data on Friday, May, 15th. The company reported ($0.68) earnings per share for the quarter. The business earned $1.02 million during the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative trailing twelve-month return on equity of 349.95%.

    Shares of BNBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Company Calendar

    Last Earnings
    5/15/2026
    Today
    8/12/2026
    Fiscal Year End
    9/30/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Industry
    Biotechnology
    Sub-Industry
    Biotechnology
    Current Symbol
    NASDAQ:BNBX
    CIK
    744452
    Employees
    70
    Year Founded
    N/A

    Profitability

    EPS (Trailing Twelve Months)
    ($36.76)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$15.16 million
    Net Margins
    -1,647.25%
    Pretax Margin
    -1,671.00%
    Return on Equity
    -349.95%
    Return on Assets
    -283.96%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    1.82
    Quick Ratio
    1.74

    Sales & Book Value

    Annual Sales
    $2.09 million
    Price / Sales
    0.52
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $1.50 per share
    Price / Book
    0.10

    Miscellaneous

    Outstanding Shares
    7,197,000
    Free Float
    6,755,000
    Market Cap
    $1.08 million
    Optionable
    N/A
    Beta
    0.60
    7 Energy Stocks to Buy and Hold Forever Cover

    With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

    Get This Free Report

    This page (NASDAQ:BNBX) was last updated on 8/12/2026 by MarketBeat.com Staff.
    From Our Partners